Three-year efficacy, safety, and survival findings from COMFORT-II, a phase 3 study comparing ruxolitinib with best available therapy for myelofibrosis
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Tiziano Barbui Francesco Passamonti Jean-Jacques Kiladjian Haifa Kathrin Al-Ali |
| Publication date | October 30, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |